arrowHome arrow News arrow Bioinformatics Companies arrow Avalonrx
Newsflash

Genehelix brings a large database of Bioinformatics companies and institutes with complete profiles and current job openings . Search here for your company profile...

Main Menu
Home
FAQ
Contact Us
Search
Wrapper
Drug design
News
Tools
Proteomics
Genomics
Software
Cheminformatics
Databases
Books
Group
Articles
Online Tutorials
Companies-Software-1
DNA-PROTEIN-ANALYSIS
Bioinformatics Course
About Us
Login Form
Username

Password

Remember me
Forgotten your password?
No account yet? Create one
Avalonrx PDF Print E-mail

Avalonrx

Avalon Pharmaceuticals' primary mission is to discover and develop innovative small molecule therapeutics using cutting-edge genomic technologies. Through its comprehensive genomics approach, Avalon is able to pinpoint proprietary drug activity markers and drug targets and to use these for drug screening in complex biological systems, facilitating the identification of lead drug candidates. Avalon is developing these drug candidates both internally and through partnerships within the pharmaceutical industry.

By attracting a leading team of innovative scientists and drug discovery experts, utilizing cutting-edge genomics tools, and forming strategic alliances within the industry, Avalon is significantly decreasing the time it takes to develop novel drug therapies to treat diseases. Within the Company's first two-years, Avalon scientists were able to use their novel genomic discovery and screening approaches to identify several small molecule drug candidates for the treatment of cancer.

Avalon identifies small molecule therapeutic compounds directly from genomics data in three steps:

Identification of novel and key proprietary drug activity markers using a comprehensive set of genomics tools including molecular and pathological characterization, cytogenetics, and high density gene expression arrays,
Screening for new small molecule therapeutic compounds using its proprietary methods such as the Company's multi-parameter assays, and
Optimization of lead compounds using cutting-edge medicinal chemistry.
The Company's initial therapeutic focus area is solid tumors including cancers of colon, breast, lung, and prostate.

Avalon's strategy of combining the latest genomic approaches for gene and target identification with an aggressive pursuit of small molecule drug discovery has attracted significant interest from the pharmaceutical industry. In order to quickly pursue large-scale discovery and drug development within particular disease areas, Avalon enters partnerships with pharmaceutical companies as well as collaborative agreements with clinical and academic institutions.
 

Careers at Avalon :

If you are interested in employment at Avalon, please feel free to send a cover letter and resume to jobs@avalonrx.com or you may fax your resume and cover letter to 301-556-9915. more

 

< Prev   Next >